KAAACI Allergic Rhinitis Guidelines: Part 1. Update in Pharmacotherapy.

ABSTRACT: The prevalence of allergic rhinitis (AR) and the socioeconomic burden associated with the medical cost and quality of life (QOL) of AR have progressively increased. Therefore, practical guidelines for the appropriate management of AR need to be developed based on scientific evidence while considering the real-world environment, values, and preferences of patients and physicians. The Korean Academy of Asthma, Allergy and Clinical Immunology revised clinical guidelines of AR to address key clinical questions of the management of AR. Part 1 of the revised guideline covers the pharmacological management of patients with AR in Korea. Through a meta-analysis and systematic review, we made 4 recommendations for AR pharmacotherapy, including intranasal corticosteroid (INCS)/intranasal antihistamin

SUBMITTER: Yang SI 

PROVIDER: S-EPMC9880301 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature